Lord et al.89 reported a significantly lower CagA-positive rate in patients with CD (0.94%) than in unaffected individuals (7.48%), suggesting that the CagA protein may participate in the IBD protective mechanism. This evidence concerns the gene S100A8 and inflammatory bowel disease.